X0306 4 2014-08-14 0 0000722830 IMMUNOMEDICS INC IMMU 0001202016 GOLDENBERG CYNTHIA L C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 1 0 President and CEO Common Stock 2014-08-14 4 A 0 105422 0.00 A 437909 D Common Stock 2014-08-14 4 A 0 105422 0.00 A 5205551 I See Footnote Stock Option (right to buy) 3.32 2014-08-14 4 A 0 200412 A 2021-08-14 Common Stock, par value $0.01 per share 200412 200412 D Stock Option (right to buy) 3.32 2014-08-14 4 A 0 200412 A 2021-08-14 Common Stock, par value $0.01 per share 200412 200412 I See Footnote Such restricted stock units were granted pursuant to the Company's 2006 Stock Incentive Plan, as amended, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein. The reporting person's spouse, Dr. David M. Goldenberg, CSO, CMO and Chairman of the Board of Directors of the Company, was granted restricted stock units pursuant to the Company's 2006 Stock Incentive Plan, as amended. Such stock options were granted pursuant to the Company's 2006 Stock Incentive Plan, as amended, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. The reporting person's spouse, Dr. David M. Goldenberg, CSO, CMO and Chairman of the Board of Directors of the Company, was granted stock options pursuant to the Company's 2006 Stock Incentive Plan, as amended. /s/ Cynthia L. Goldenberg 2014-08-18